Biopharma Trends 2025: 3 Things to Know Right Now
The global business climate is ever-evolving, and 2025 looks like it may be particularly challenging. Nowhere is that more evident than in the biopharma space, which is contending with multiple factors including a new administration in the US, new regulatory requirements in the EU, supply chain issues, and an uncertain economy. Despite these obstacles, however,…...
Read MoreTop Stories
Science, AI, and Human Ingenuity Converge to
Today, we're witnessing an unprecedented convergence of...
The Paradigm Shift from Traditional Scientific
In the rapidly evolving biopharma landscape, the approach to...
Leveraging Social Media to Transform Medical
This whitepaper explores the role of social media in...
Filter
Clinical Trial Summaries – What Are They and Why Do They Matter for Pharma?
A majority of patients feel lay summaries for clinical trials are very important and won’t...
How Can Preprints Drive Trust in Science?
By tagging preprints with various indicators, badges may represent quality, rigor, and scope. In doing...
How to Incorporate and Drive Equity, Diversity, and Inclusion in Medical Communications and Publications
A roadmap on how to drive advocacy for EDI in medical communications and publications and...
Vision 2025: Decoding the Medical Affairs Landscape
Medical Affairs is a critical strategic pillars of pharma. Read how Medical Affairs will evolve...
Using Digital Enhancements to Maximize Engagement: How Are Pharma and Publishers Embracing Digital?
Best practices to implement digital enhancements and measure effectiveness...
Preprints and Pharma: What Works and What Doesn’t
Pharma is cautious of preprints. But should this change? Let’s weigh the pros & cons...